Lv3
400 积分 2023-02-14 加入
Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
6天前
已完结
Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns
6天前
已完结
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
1个月前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
4个月前
已完结
Myasthenia Gravis
4个月前
已完结
The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell–derived leukocyte elastase
5个月前
已完结
Positioning challenges in mammography
5个月前
已关闭
Rates of Adverse Events per Patient-Year in a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes
5个月前
已关闭
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
6个月前
已完结
Clinical efficacy of anti-CD20 antibodies in neurological and neuromuscular diseases
6个月前
已完结
皖公网安备34019202002308
